Prostate Cancer Clinical Trial

Proton Therapy for Low and Intermediate Risk Prostate Cancer

Summary

The purpose of this trial is to give a shorter course (5 ½ weeks) of radiation that has as little side effects on normal bladder and rectal tissues as the usual longer course (8 weeks) of radiation, without decreasing the chance of killing prostate cancer cells.

View Full Description

Full Description

Low Risk - Total of 70 Gy/CGE over 28 treatments

Intermediate Risk - Total of 72.5 Gy/CGE over 29 treatments

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria

Prostate cancer.
Gleason score 2-7.
PSA ≤ 20 ng/ml.

Exclusion Criteria:

Previous prostate cancer surgery or pelvic radiation.
Prior or current chemotherapy for prostate cancer.
Active inflammatory bowel disease (Crohn's disease, diverticulitis or ulcerative colitis) affecting the rectum.
History of proximal urethral stricture requiring dilatation.
History of hip replacement.
Diabetes requiring medication.
Prior intrapelvic surgery.
Current and continuing anticoagulation with Warfarin sodium (Coumadin), Clopidogrel bisulfate (Plavix), enoxaparin sodium (Lovenox), or aspirin/er dipyridamole (Aggrenox).
On Flomax (Tamsulosin), Hytrin (Terazosin) or Cardura (Doxazosin), Uroxatral (alfuzosin HCl).
Taking Saw Palmetto or methotrexate and unable or unwilling to discontinue its use during radiation.

Study is for people with:

Prostate Cancer

Estimated Enrollment:

228

Study ID:

NCT00693238

Recruitment Status:

Completed

Sponsor:

University of Florida

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Florida Proton Therapy Institute
Jacksonville Florida, 32206, United States

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

228

Study ID:

NCT00693238

Recruitment Status:

Completed

Sponsor:


University of Florida

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.